Evermay Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9
Closed -$110 589
2025
Q3
$110 Hold
9
﹤0.01% 543
2025
Q2
$168 Hold
9
﹤0.01% 554
2025
Q1
$173 Hold
9
﹤0.01% 565
2024
Q4
$325 Buy
+9
New +$304 ﹤0.01% 546
2022
Q3
Sell
-9
Closed -$1K 558
2022
Q2
$1K Hold
9
﹤0.01% 501
2022
Q1
$1K Hold
9
﹤0.01% 508
2021
Q4
$1K Hold
9
﹤0.01% 497
2021
Q3
$1K Hold
9
﹤0.01% 441
2021
Q2
$1K Buy
+9
New +$803 ﹤0.01% 493

Other funds holding TNDM

Evermay Wealth Management's TNDM Position: Q4 2025 in Review

Evermay Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 9 shares — an estimated $110 sold.

Evermay Wealth Management first reported a position in TNDM in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q2 2022. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Evermay Wealth Management reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Evermay Wealth Management sold 9 Tandem Diabetes Care shares in Q4 2025, an estimated $110.
  • Evermay Wealth Management first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 9 quarters.
  • Evermay Wealth Management's Tandem Diabetes Care position peaked at $1K in Q2 2022.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Evermay Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.